Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD

1.090

+0.010 (0.93%)

At close: Jul 19, 2024, 4:00 PM

1.140

+0.050 (4.59%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Adial Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Selling, General & Admin	5.11	5.62	8.91	9.34	5.07	4.28	Upgrade
Research & Development	1.36	1.27	1.95	8.4	5.85	3.97	Upgrade
Other Operating Expenses	0	0	0	1.55	0	0	Upgrade
Operating Expenses	6.46	6.89	10.86	19.29	10.93	8.24	Upgrade
Operating Income	-6.46	-6.89	-10.86	-19.29	-10.93	-8.24	Upgrade
Other Expense / Income	2.23	-1.76	1.87	0.23	-0.03	0.35	Upgrade
Pretax Income	-8.69	-5.12	-12.73	-19.52	-10.89	-8.59	Upgrade
Income Tax	0	0	0	-0.09	0	0	Upgrade
Net Income	-8.69	-5.12	-12.73	-19.42	-10.89	-8.59	Upgrade
Shares Outstanding (Basic)	3	1	1	1	0	0	Upgrade
Shares Outstanding (Diluted)	3	1	1	1	0	0	Upgrade
Shares Change	179.05%	42.25%	34.69%	49.15%	26.50%	107.01%	Upgrade
EPS (Basic)	-3.15	-3.60	-12.71	-26.00	-21.75	-21.75	Upgrade
EPS (Diluted)	-3.15	-3.60	-12.71	-26.00	-21.75	-21.75	Upgrade
Free Cash Flow	-6.13	-6.81	-11.19	-12.01	-7.63	-6.34	Upgrade
Free Cash Flow Per Share	-2.08	-4.78	-11.17	-16.16	-15.31	-16.08	Upgrade
EBITDA	-8.71	-5.12	-12.73	-19.46	-10.89	-8.59	Upgrade
Depreciation & Amortization	-0.02	0	0	0.06	0	0	Upgrade
EBIT	-8.69	-5.12	-12.73	-19.52	-10.89	-8.59	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).